Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stage I Prostate Adenocarcinoma AJCC v7 1

Interventions

Cisplatin 18Magnetic Resonance Spectroscopy 14Specimen Handling 12Gemcitabine 12Carboplatin 12pembrolizumab 11Paclitaxel 9Platinum 7Pemetrexed 71,2-diaminocyclohexaneplatinum II citrate 7atezolizumab 6Radiotherapy, Intensity-Modulated 6Radiotherapy 6Radiation 6Nivolumab 6Doxorubicin 6Surgical Procedures, Operative 5Rituximab 5Immunoglobulin G 5Docetaxel 5Disulfides 5Biopsy 5Bevacizumab 5130-nm albumin-bound paclitaxel 5Temozolomide 4Drug Therapy 4Dexamethasone 4Cyclophosphamide 4Cetuximab 4venetoclax 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × luprolide acetate gel depot × 30 days × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡